http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020092402-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9cb1434c157d7e3f294d7022d7b1ee73
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-401
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
filingDate 2019-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de02b9a205209d17072a34873d0503f6
publicationDate 2020-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020092402-A1
titleOfInvention Pharmaceutical compositions of tiopronin and methods for preparing thereof
abstract Pharmaceutical compositions are described herein, the compositions consisting essentially of anhydrous suspensions of a therapeutically effective quantity of a pharmaceutically acceptable reducing agent capable of undergoing thiol-disulfide exchange with cystine to form a mixed disulfide (such as tiopronin). In some embodiments, the suspension also contains one or more urine alkanizing agent(s). Methods for fabricating the compositions and using them are also described.
priorityDate 2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017172960-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010204324-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9701656-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017087179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017112804-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401013
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67678
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3036261

Total number of triples: 31.